CDTVSGTBP• 3 Months (Normalized)
CDT vs GTBP (CDT Equity Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.14
-97.68%
CDT Equity Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+1513.64%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1611.32 pts
GTBP outperforming by 1611.32 percentage points
CDTGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | CDT Price | CDT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $0.14 | -97.68% | $7.10 | +1513.64% | -1611.32% |
| Sep 22, 2026 | $0.14 | -97.56% | $- | - | |
| Sep 21, 2026 | $0.15 | -97.36% | $7.18 | +1531.82% | -1629.18% |
| Sep 18, 2026 | $0.17 | -97.02% | $7.16 | +1527.27% | -1624.29% |
| Sep 17, 2026 | $0.19 | -96.74% | $7.49 | +1602.27% | -1699.01% |
| Sep 16, 2026 | $0.20 | -96.60% | $7.81 | +1675.00% | -1771.60% |
| Sep 15, 2026 | $0.20 | -96.52% | $9.00 | +1945.45% | -2041.97% |
| Sep 14, 2026 | $0.22 | -96.24% | $11.63 | +2543.18% | -2639.42% |
| Sep 11, 2026 | $0.25 | -95.71% | $8.61 | +1856.82% | -1952.53% |
| Sep 10, 2026 | $0.35 | -94.08% | $6.18 | +1304.55% | -1398.63% |
| Sep 09, 2026 | $0.60 | -89.71% | $5.98 | +1259.09% | -1348.80% |
| Sep 08, 2026 | $0.62 | -89.42% | $- | - | |
| Sep 04, 2026 | $0.63 | -89.28% | $0.24 | -45.23% | -44.05% |
| Sep 03, 2026 | $0.75 | -87.15% | $0.25 | -42.73% | -44.42% |
| Sep 02, 2026 | $0.91 | -84.39% | $0.28 | -35.68% | -48.71% |
Page 1 of 5